Latin America Meningococcal Vaccines Market Size & Outlook
Latin America meningococcal vaccines market, 2018-2030 (US$M)
Related Markets
Latin America meningococcal vaccines market highlights
- The Latin America meningococcal vaccines market generated a revenue of USD 81.4 million in 2021.
- The market is expected to grow at a CAGR of 6.6% from 2022 to 2030.
- In terms of segment, quadrivalent was the largest revenue generating type in 2021.
- Quadrivalent is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Cuba is expected to register the highest CAGR from 2022 to 2030.
Latin America data book summary
| Market revenue in 2021 | USD 81.4 million |
| Market revenue in 2030 | USD 145.1 million |
| Growth rate | 6.6% (CAGR from 2021 to 2030) |
| Largest segment | Quadrivalent |
| Fastest growing segment | Quadrivalent |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bivalent, Quadrivalent |
| Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
Other key industry trends
- In terms of revenue, Latin America region accounted for 2.8% of the global meningococcal vaccines market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 141.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Meningococcal Vaccines Market Scope
Meningococcal Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America meningococcal vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 69.9% in 2021. Horizon Databook has segmented the Latin America meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
In Latin America region, Brazil, Mexico, Argentina are major market for meningococcal vaccines. According to an article published in the International Journal of Infectious Disease, in 2019, Brazil, Chile, and Argentina reported the highest number of IMD cases, whereas Mexico recorded lowest disease incidence, due to underreporting of cases.
Increase in the incidence of meningitis serogroup A, B, C, Y, & W leads to rise in mortality rates, which is expected to fuel market growth. Due to low awareness level about meningococcal disease among people and underreported cases of IMD underestimate the real burden of the disease in the region.
However, improvement in meningococcal disease diagnosis, monitoring, and registration is anticipated to boost market growth during the forecast period. Presence of favorable government initiatives and research collaborations are anticipated to contribute to market growth.
Reasons to subscribe to Latin America meningococcal vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America meningococcal vaccines market databook
-
Our clientele includes a mix of meningococcal vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America meningococcal vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America meningococcal vaccines market size, by country, 2018-2030 (US$M)
Latin America Meningococcal Vaccines Market Outlook Share, 2021 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
